Cargando…
OBHS Drives Abnormal Glycometabolis Reprogramming via GLUT1 in Breast Cancer
Due to the poor metabolic conditions fomenting the emergence of the Warburg effect (WE) phenotype, abnormal glycometabolism has become a unique and fundamental research topic in the field of tumor biology. Moreover, hyperglycemia and hyperinsulinism are associated with poor outcomes in patients with...
Autores principales: | Wang, Kexin, Li, Qiuzi, Fan, Yufeng, Fang, Pingping, Zhou, Haibing, Huang, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10138908/ https://www.ncbi.nlm.nih.gov/pubmed/37108300 http://dx.doi.org/10.3390/ijms24087136 |
Ejemplares similares
-
Occult Hepatitis B (OBH) in Clinical Settings
por: Alavian, Seyed Moayed, et al.
Publicado: (2012) -
Expression of GLUT1 and GLUT3 Glucose Transporters in Endometrial and Breast Cancers
por: Krzeslak, Anna, et al.
Publicado: (2012) -
Leukemia inhibitory factor drives glucose metabolic reprogramming to promote breast tumorigenesis
por: Yue, Xuetian, et al.
Publicado: (2022) -
GLUT-1 Expression in Breast Cancer
por: Okcu, Oguzhan, et al.
Publicado: (2022) -
GLUT4, GLUT1, and GLUT8 are the dominant GLUT transcripts expressed in the murine left ventricle
por: Aerni-Flessner, Lauren, et al.
Publicado: (2012)